Overview

Explorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or Stomach

Status:
Completed

Trial end date:
2016-09-12

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the rate of complete pathological responses (percentage of patients with pCR referring to the total number of enrolled and eligible patients), as evaluated centrally by a reference pathologist.

Phase:

Phase 2

Details

Lead Sponsor:

AIO-Studien-gGmbH

Collaborator:

Roche Pharma AG

Treatments:

Docetaxel
Leucovorin
Oxaliplatin
Trastuzumab